Scanned by

    Norton

    Norton™ Safe Web

    Exposure to endocrine-disrupting chemicals and implications for neurodevelopment | Ozel | DMCN

    Exposure to endocrine-disrupting chemicals and implications for neurodevelopment | Ozel | DMCN

    03:00 |
    Download Here

    You Might Also Like:

    To Enhance Function, Promote Children’s Development | Peter Rosenbaum | DMCN

    To Enhance Function, Promote Children’s Development | Peter Rosenbaum | DMCN

    5:52 |
    A Manifesto for Cerebral Palsy | John Coughlan & Agnes Kojc | DMCN

    A Manifesto for Cerebral Palsy | John Coughlan & Agnes Kojc | DMCN

    3:41 |
    Cochrane SREs for rehabilitation interventions in individuals with cerebral palsy | Ligouri | DMCN

    Cochrane SREs for rehabilitation interventions in individuals with cerebral palsy | Ligouri | DMCN

    5:21 |
    Childhood disability: the importance of context | Rosenbaum | DMCN

    Childhood disability: the importance of context | Rosenbaum | DMCN

    8:10 |
    Exposure to endocrine-disrupting chemicals and implications for neurodevelopment | Ozel | DMCN

    Exposure to endocrine-disrupting chemicals and implications for neurodevelopment | Ozel | DMCN

    3:01 |
    Towards a Definition of Neurodisability: A Delphi Survey | Christopher Morris | DMCN

    Towards a Definition of Neurodisability: A Delphi Survey | Christopher Morris | DMCN

    23:46 |
    Autism Spectrum Disorder: Disparities in Adversity Among Children | Michael Msall | DMCN

    Autism Spectrum Disorder: Disparities in Adversity Among Children | Michael Msall | DMCN

    1:12 |
    Power Mobility Skill Progression for Children | Debra Field & Roslyn Livingstone | DMCN

    Power Mobility Skill Progression for Children | Debra Field & Roslyn Livingstone | DMCN

    2:38 |
    Attention and motor profiles in children with DCD | Bonthrone et al. | DMCN

    Attention and motor profiles in children with DCD | Bonthrone et al. | DMCN

    1:35 |
    Australian & New Zealand Cerebral Palsy Strategy | RJ Mitte, Badawi & Honan | DMCN

    Australian & New Zealand Cerebral Palsy Strategy | RJ Mitte, Badawi & Honan | DMCN

    4:23 |
    Motor Phenotypes in Ataxia, Developmental Coordination Disorder and Hypotonia | Deborah Sival | DMCN

    Motor Phenotypes in Ataxia, Developmental Coordination Disorder and Hypotonia | Deborah Sival | DMCN

    5:59 |
    Safety and efficacy of NIB for the upper extremities in children with CP | Metelski | DMCN

    Safety and efficacy of NIB for the upper extremities in children with CP | Metelski | DMCN

    5:26 |
    Promoting peace of mind: Wellness in children with disabilities and their families | Shrader | DMCN

    Promoting peace of mind: Wellness in children with disabilities and their families | Shrader | DMCN

    3:51 |
    Intracranial Calcification: Recognizable Phenotypes | DMCN

    Intracranial Calcification: Recognizable Phenotypes | DMCN

    23:14 |
    School participation: young people with craniofacial microsomia & other disabilities | Kaelin | DMCN

    School participation: young people with craniofacial microsomia & other disabilities | Kaelin | DMCN

    5:21 |
    Who is ‘Promoting Physical Activity and Fitness’ for? Maltais and Jahnsen tell us #child #disability

    Who is ‘Promoting Physical Activity and Fitness’ for? Maltais and Jahnsen tell us #child #disability

    0:45 |
    Performance of Upper Limb Module for Duchenne Muscular Dystrophy | Anna Mayhew | DMCN

    Performance of Upper Limb Module for Duchenne Muscular Dystrophy | Anna Mayhew | DMCN

    2:14 |
    Wheeled mobility skill interventions in children & young people with cerebral palsy | Naaris | DMCN

    Wheeled mobility skill interventions in children & young people with cerebral palsy | Naaris | DMCN

    5:22 |
    Health care concerns in parents of children with genetic DEEs | Palacios-Ceña | DMCN Spanish

    Health care concerns in parents of children with genetic DEEs | Palacios-Ceña | DMCN Spanish

    0:54 |
    Relapse Risk Factors in Anti-N-methyl-D-aspartate Receptor Encephalitis | Margherita Nosadini | DMCN

    Relapse Risk Factors in Anti-N-methyl-D-aspartate Receptor Encephalitis | Margherita Nosadini | DMCN

    4:23 |